Biomarker level ([TIMP-2]∙[IGFBP7] (0.3 ng/mL)2/1000) and time point of measurement (4 h after cardiopulmonary bypass) resulted in a successful predictive performance of those patients at high risk of AKI development. This evidence concerns the gene IGFBP7 and acute kidney injury.